
Bridgwater outreach: 'It's so hard leaving women sleeping rough'
Now 38, Sarah "didn't feel quite so alone" once she found the Bridgwater Women's Centre team after one of many arrests for shoplifting, when she was sent to prison for her second time."That's when I'd had enough. I really missed my kids, obviously I always miss my children, but that's when it clicked like nothing's gonna change until I got off the stuff. "Now, being clean, everything else just falls into place," she said.For the outreach team, Sarah's is a huge success story.No longer sleeping rough, she is now in temporary accommodation and hoping to go to college later this year.She also sees her son everyday which she said is "amazing – I didn't ever think I'd get that back".And she's been been off methadone for the last six weeks: "I'm quite proud of that," Sarah admitted.Other women Dani and her colleague have seen are still in difficult situations.
"All the women I support are homeless, they also have complex needs regarding mental health, substance misuse, family breakdowns, they might be facing violence from a partner or another individual," said Dani.On this particular evening she'd managed to see ten women, three of whom were new or she hadn't seen for a long time."They were in parks, in town, we've seen women in tents, also outside the town centre who have made what they feel is a safe environment - but that's a risky situation to be in," she said.As well as handing out food and supplies, Dani and her colleague have also given out advice.Once a month they're joined by sexual health nurses for the evening. On this occasion they've helped one woman get emergency accommodation for the night and sent emails to "many different professionals" to help others.
Night-time 'most risky'
"We've got a GP coming in to the centre tomorrow so we were able to get four women to agree to come in and see the GP who don't currently access medical support - having that place of safety and that little prompt tonight has really helped," said Dani.Dani said it's difficult leaving the women she comes into contact with."In the evening, through the night-time, that's when women are at risk of violence - whether that's physical or sexual - because they're so vulnerable.""The risks can women can be put into, and the risks that come to them when they're asleep - they're scared," she said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
19 minutes ago
- The Independent
Molly-Mae says daughter Bambi has been part of ‘biting pandemic' at nursery
Molly-Mae Hague has revealed that her daughter Bambi is part of a 'biting pandemic' at her nursery, as she admits she 'doesn't know' the best way to deal with her two-year-old's behaviour. In a vlog posted to YouTube on Sunday (17 August), the influencer said that Bambi's nursery contacted her to tell her that her child has been biting others. 'Basically at her nursery at the minute, there's a bit of a biting pandemic going on and all of the children are biting one another.' The 26-year-old mother said she was torn on whether to treat Bambi to ice cream later that day, as she was concerned that it was a 'reward for bad behaviour'. However, she said she didn't know if she 'should bring attention to it', as she believes Bambi may be biting 'to get a reaction'.


The Sun
20 minutes ago
- The Sun
Children's vitamin gummies urgently recalled due to fears they contain prescription sleep drug
VITAMIN gummies for kids have been urgently recalled over fears they contain a prescription-only sleep drug. The Medicines and Healthcare products Regulatory Agency (MHRA) told parents who'd bought Nutrition Ignition Kids Magnesium Glycinate Gummies for their kids to "stop all use" immediately. It said testing had identified undeclared melatonin - a prescription only medicine used to treat sleep disorders - in certain batches. Ingestion of melatonin won't cause "lasting harm" in kids, the MHRA said. But it can leave children feeling drowsy, dizzy or nauseous if they take too much. The health watchdog is also working with online retailers to remove the gummies from sale. Magnesium glycinate is a dietary supplement that can help with anxiety and improve sleep. The Nutrition Ignition Kids Magnesium Glycinate Gummies are marketed to children above the age of four to support "calm, focus, and digestion". But tests on two batches of vitamins showed between 1.5 and 1.7mg of melatonin in each individual gummy. Melatonin, the hormone that helps regulate the sleep-wake cycle, is naturally produced by the body. However, a synthetic version can be prescribed to adults and children over the age of six in UK if they suffer from sleep disorders such as insomnia. If prescribed, the recommended starting dose is 1mg for children. Your ultimate sleep toolkit in 13 steps - from recording snoring to daylight hack According to the MHRA, melatonin is not listed anywhere on the packaging of Nutrition Ignition Kids Magnesium Glycinate Gummies. The packaging advises a dose of one to two gummies per day, depending on the child's age. "Lasting harm is not expected when ingesting melatonin at high levels, and the body typically clears this within 12 hours," the MHRA said. But taking too much melatonin can cause headaches, drowsiness, dizziness and nausea, the health watchdog added. Dr Alison Cave, chief safety officer at MHRA, said: "We advise any parent or caregiver to stop use of this product and safely dispose of it. "Side effects such as headache, hyperactivity, a feeling of dizziness and abdominal pain have been reported in children when melatonin is prescribed and used for its licensed indications. "No serious side effects were observed in studies in children. "Anyone who suspects that their child, or a child in their care, is having a side effect from this product is advised to stop taking it and speak to a healthcare professional and report it directly to the MHRA Yellow Card scheme." Nutrition Ignition Kids Magnesium Glycinate Gummies are sold online as a food supplement, but the MHRA has now removed the product from sale and is working with online retailers to remove all listings. Parents or care givers who have this product at home were advised to store it securely in a tamper-proof container out of reach of children until they can take it to a pharmacy for disposal. What is melatonin and who can't take it? Melatonin is a hormone that occurs naturally in your body. At night, your levels of melatonin rise, before returning to normal during the day. This helps to control how and when you sleep. You can take a synthetic version of melatonin for short periods if you have sleep problems such as insomnia. This adds to your body's natural supply of melatonin, so you fall asleep more quickly and you're less likely to wake up during the night. It may also help with symptoms of jetlag. Melatonin is mainly used to treat short-term sleep problems in people aged 55 or over. It can also sometimes be prescribed by specialists to help with longer-term sleep problems in some children and adults. Melatonin is available on prescription only. It's not suitable for some people. To make sure it's safe for you, tell your doctor or pharmacist before taking it if you: Have ever had an allergic reaction to melatonin or any other medicine Have liver or kidney problems Have rheumatoid arthritis, multiple sclerosis or lupus, or any other autoimmune condition Side effects of melatonin Melatonin doesn't have many common side effects but it can cause the following: Source: NHS


Daily Mail
20 minutes ago
- Daily Mail
Revealed: The bizarre new dinner party etiquette rule for 2025 - as almost half of people say the gatherings are 'ruined' completely
Dinner party guests should let their hosts known in advance if they're taking weight loss jabs such as Ozempic, according to a bizarre new etiquette rule. Six in ten Brits (61 per cent) believe the correct modern etiquette is to call ahead of a dinner or lunch party - to notify the host you are taking weight loss drugs, according to a new study. An estimated 1.5 million Britons are now using Ozempic, Mounjaro or Wegovy, yet 20 per cent of party hosts say they have been annoyed at having cooked a delicious meal, only for guests to push food around their plate. The study was carried out by insights agency Perspectus Global and surveyed 2,000 Brits. Of those who are on the drugs, as many as 80 per cent agree, they now find the social side of eating and drinking uncomfortable. Nearly half (47 per cent) say that they have ruined their enjoyment of dinner parties entirely. Almost a quarter (22 per cent) have offended a host, by being unable to eat the food they'd prepared, while one in ten have even hidden food in a napkin at someone's house to avoid embarrassment. And it's not just food that's spoiled, with 18 per cent of those on injections saying that they can no longer enjoy nice wine or cocktails. Harriet Scott from insights agency Perspectus Global which carried out the survey of 2,000 Brits, said: 'Weight loss drugs may be a cure for obesity that we've been looking for, for decades, but we're still in the early days of their use and they will have ripple effects which we won't be aware of yet. 'The fact that their use can make social eating difficult is just one unforeseen effect. 'This research proves that shared meals may become more awkward until we work past the social difficulties and adapt our menus.' And the data has revealed a list of 20 injection friendly dinner party dishes, for those cooking for guests with little, to no appetite. Among the list was a small prawn cocktail (21 per cent) melon and prosciutto (15 per cent), fish soup (13 per cent) or a small fillet steak with some simple greens (18 per cent). While 14 per cent of hosts say a sorbet makes a great choice of pudding, and to start, rather than filling appetisers, some simple crudités and dips (14 per cent) Salmon Gravadlax, Thai beef salads, sashimi and prawn summer rolls are other options one may consider when throwing a soiree for guests on a medical weight-loss programme. It comes after Mounjaro manufacturer Lilly sparked panic among slimmers after revealing it would more than double the price of the drug in the UK. The US pharmaceutical giant announced the cost would soar from September 1, with the wholesale price of a month's supply of the highest dose rising from £122 to £330. Lilly claimed it had initially launched Mounjaro in the UK at a price 'significantly below the European average to prevent delays in NHS availability' but that this must now change 'to ensure fair global contributions to the cost of innovation'. The announcement, however, does not affect the price the NHS pays, as the service has negotiated a heavily discounted rate for those getting the drug on prescription. But there are thought to be around 1.5 million people on weight loss drugs in the UK with more than half of them on Mounjaro—and estimates suggest nine in 10 pay for these drugs privately. Users flocked to social media warning denouncing the move, worried they were now left with no option but to come off the 'life changing' jab. 'I have no one to talk to about this and I'm freaking out,' one wrote on Reddit. 'Call it dramatic but I just cannot afford this, and this med is my only lifeline right now. I'm absolutely devastated. I don't know what to do.' Another said: 'I'm totally freaking out about it! I'm only about to go onto my 2nd pen now. The black market is going to be even more rife than ever due to this, fuming.' The main concern among slimmers is regaining weight after being forced to stop Mounjaro. Evidence suggests currently only around 2 to 10 per cent of people keep all their lost weight off if they stop taking the jabs, known collectively as GLP-1s. The spread of 'fat jabs' such as Ozempic could lead to a rise in the state pension age because previously obese workers will live longer than expected, Government advisers have warned. Users of the drugs, which also include Mounjaro and Wegovy, typically lose about 15 per cent of their body weight, leading to knock-on health benefits such as lower cholesterol levels and reduced blood pressure. A Government source told The Mail on Sunday yesterday: 'Obviously everyone can see the health benefits. But some people in the Treasury are worried about the impact on the pension crisis. Obesity is a big killer. 'And if people are starting to live a lot longer because they're not overweight that's quickly going to become an issue. Especially if we're going to see it regularly being prescribed on the NHS, as Wes is advocating.'